with increased accumulation of ROS that leads to JNK and STAT3 activation [11] . The positive cross-talk between JNK and stem cell expansion is evident in human HCC studies [12] . Deletion of p38α, which leads to JNK activation, upregulates expression of SOX2 and Gankyrin, which may be involved in cancer stem cell maintenance [3] . The NF-κB/STAT3/JNK signaling pathway in cancer stem cells may be a promising therapeutic target.
The molecular etiology of HCC has been extensively studied using transgenic or chemically induced mouse models [13, 14] . The chemical procarcinogen diethylnitrosamine (DEN)-induced HCC depends on production of the NF-κB-regulated cytokine IL-6 by resident Kupffer cells [15] . In this case, Kupffer cells are activated by IL-1α released by apoptosing hepatocytes [5] . Interestingly, male mice produce more IL-6 upon DEN administration than females, which accounts for the marked male bias in HCC induction studies. Mice administered thioacetamide for 10 months develop HCCs subsequent to appearance of severe liver fibrosis, thus providing a model that closely mimics the natural history of human HCVrelated liver disease [3] . These animal models are critical for finding answers to key questions raised by the authors.
Unlike most solid tumors, the incidence and mortality of HCC have increased in the United States and Europe in the past decade. The findings implicating a pivotal signaling pathway in HCC development suggest the potential use for blocking agents and/or modulators for HCC treatment. Therefore, it is important to improve our understanding of the molecular pathogenesis of HCC.
